Autologous Blood Derived Signaling Proteins for Tendon and Muscle Therapy in Sports Medicine Higher Concentration of Growth Factors and Cytokines in Orthokine VS in ACP
We compared 2 none-PRP techniques: ORTHOKINE (Oe) for Autologous Conditioned Serum (ACS) and ACP (Ax) for autologous plasma (AP)
Does Tranexamic Acid Stop Haemoptysis
Current best evidence indicates that tranexamic acid may reduce both the duration and volume of bleeding, with low risk of short-term thromboembolic complications, in patients with haemoptysis.
Cardiac Surgery in a Patient with Severe Thrombocytopenia: How Low is Too Low
We report a case of severe thrombocytopenia (19 × 10 9 /L) where coronary artery bypass grafting was performed with minimal blood loss post-operatively, discuss the patient's management and provide insights while dealing with such patients.
Comparison of Epsilon Aminocaproic Acid and Tranexamic Acid in Thoracic Aortic Surgery: Clinical Efficacy and Safety
This study evaluates the efficacy and safety of tranexamic acid (TXA) versus epsilon aminocaproic acid (EACA) in patients undergoing thoracic aortic surgery.
How Effective are Injection Treatments for Lateral Epicondylitis
We compared the effectiveness, after 3 months, of a single injection of platelet-rich plasma (PRP), glucocorticoid (GC), or saline in reducing pain in lateral epicondylitis.
Achilles Tendinopathy Management: A Pilot Randomized Controlled Trial Comparing Platelet-Rich Plasma Injection with an Eccentric Loading Programme
We conducted a pilot randomized controlled trial to evaluate the feasibility of conducting a larger trial to evaluate the difference in Victorian Institute of Sports Assessment-Achilles (VISA-A) scores at six months between patients with Achilles tendinopathy treated with a platelet-rich plasma (PRP) injection compared with an eccentric loading programme.
Comparison of the Effects of Albumin 5%, Hydroxyethyl Starch 130/0.4 6%, and Ringer’s Lactate on Blood Loss and Coagulation after Cardiac Surgery
We randomly assigned 240 patients undergoing elective cardiac surgery to receive up to 50 ml kg-1 day-1 of either HA, HES, or Ringer's lactate (RL) as the main infusion fluid perioperatively.
Implementation of an Institutional Protocol for Rational Use of Blood Products and Its Impact on Postoperative of Coronary Artery Bypass Graft Surgery
We evaluated the short-term effects of implementation of a protocol for the rational use of blood products in the perioperative period of cardiac surgery.
Prospective Clinical Trial on dosage Optimizing of Tranexamic Acid in Non-Emergency Cardiac Surgery Procedures
After withdrawal of aprotinin in 2008 only tranexamic acid (TxA, Cyclocapron, Pfitzer, Germany) remains available as antihyperfibrinolytic agent in Europe.
Population Pharmacokinetics of Tranexamic Acid in Adults Undergoing Cardiac Surgery with Cardiopulmonary Bypass
The objectives of this study were to investigate the population pharmacokinetics (PK) of tranexamic acid (TA) given with either low- or high-dose continuous infusion schemes in adult cardiac surgery patients during cardiopulmonary bypass (CPB).
Enhancing Intervertebral Disc Repair and Regeneration Through Biology: Platelet-Rich Plasma as an Alternative Strategy
This review describes the current understanding of intervertebral disc degeneration (IDD) and related biological therapeutic strategies, especially the promising prospects of PRP treatment.
New Oral Anticoagulants: Comparative Pharmacology with Vitamin K Antagonists
New oral anticoagulants (OACs) that directly inhibit Factor Xa (FXa) or thrombin have been developed for the long-term prevention of thromboembolic disorders.